<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Vitamin K2 is reported to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> or differentiation of leukemic cell lines in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>We administered a vitamin K2 analog, menatetrenone, at 45 mg daily to 23 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>): 13 patients with RA, 2 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>, 6 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and 2 with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Good response (GR) and partial response (PR) were defined as an increase of <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> concentration exceeding 2 g/dl and 1-2 g/dl without transfusion, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Six of the RA patients showed improvement of <z:hpo ids='HP_0001903'>anemia</z:hpo> (GR, 3 patients; PR, 3 patients) </plain></SENT>
<SENT sid="4" pm="."><plain>RA patients who did not have a <z:e sem="disease" ids="C0151773" disease_type="Disease or Syndrome" abbrv="">hypocellular bone marrow</z:e> and were transfusion-independent tended to be responsive to vitamin K2 therapy in combination with <z:chebi fb="0" ids="28940">vitamin D3</z:chebi> or <z:e sem="disease" ids="C1456831" disease_type="Mental or Behavioral Dysfunction" abbrv="">anabolic steroids</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>No adverse effect of vitamin K2 was observed, and the time required to obtain the hematological response was short, being 3 months on average </plain></SENT>
<SENT sid="6" pm="."><plain>We believe that vitamin K2 therapy has potential as a treatment for patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>